Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$1.42B |
| 2 |
Johnson & Johnson
JNJ
|
+$685M |
| 3 |
SLB Ltd
SLB
|
+$281M |
| 4 |
Mondelez International
MDLZ
|
+$241M |
| 5 |
Alibaba
BABA
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$377M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$296M |
| 3 |
Amgen
AMGN
|
+$278M |
| 4 |
GGP
GGP Inc.
GGP
|
+$250M |
| 5 |
Electronic Arts
EA
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.74% |
| 2 | Financials | 13.21% |
| 3 | Healthcare | 12.3% |
| 4 | Consumer Discretionary | 11.6% |
| 5 | Communication Services | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRA
1676
DELISTED
ProAssurance
PRA
| $9.39M | ﹤0.01% |
200,096
-235,754
| -54% | -$10.4M |
|
|
CSII
1677
DELISTED
Cardiovascular Systems, Inc.
CSII
| $9.39M | ﹤0.01% |
239,999
+15,047
| +7% | +$556K |
|
1678
Boise Cascade
BCC
$2.69B
| $9.38M | ﹤0.01% |
254,904
-12,822
| -5% | -$558K |
|
1679
Insulet
PODD
$11.5B
| $9.35M | ﹤0.01% |
88,267
+32,122
| +57% | +$3.01M |
|
|
NVO
1680
Novo Nordisk
NVO
$208B
| $9.34M | ﹤0.01% |
396,336
-2,250
| -0.6% | -$54.9K |
|
|
GTLS
1681
DELISTED
Chart Industries
GTLS
| $9.33M | ﹤0.01% |
119,071
+12,665
| +12% | +$938K |
|
1682
Invesco Senior Income Trust
VVR
$457M
| $9.31M | ﹤0.01% |
2,165,670
+145,008
| +7% | +$625K |
|
1683
Factset
FDS
$9.36B
| $9.3M | ﹤0.01% |
41,567
+266
| +0.6% | +$57.7K |
|
1684
BlackRock Limited Duration Income Trust
BLW
$490M
| $9.3M | ﹤0.01% |
624,323
+49,284
| +9% | +$736K |
|
|
CATM
1685
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $9.28M | ﹤0.01% |
293,200
-8,226
| -3% | -$253K |
|
1686
Lattice Semiconductor
LSCC
$17.6B
| $9.26M | ﹤0.01% |
1,157,090
+992,536
| +603% | +$7.33M |
|
1687
Scansource
SCSC
$1.15B
| $9.24M | ﹤0.01% |
231,606
+13,844
| +6% | +$567K |
|
|
KMI.PRA
1688
DELISTED
Kinder Morgan, Inc.
KMI.PRA
| $9.24M | ﹤0.01% |
277,888
| – | – |
|
1689
AAR Corp
AIR
$5.59B
| $9.23M | ﹤0.01% |
192,767
+9,235
| +5% | +$424K |
|
1690
BlackRock Debt Strategies Fund
DSU
$593M
| $9.21M | ﹤0.01% |
826,302
+150,246
| +22% | +$1.69M |
|
1691
The Greenbrier Companies
GBX
$1.52B
| $9.2M | ﹤0.01% |
153,002
+15,260
| +11% | +$880K |
|
|
WIW
1692
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$505M
| $9.19M | ﹤0.01% |
847,729
+38,943
| +5% | +$429K |
|
1693
Heron Therapeutics
HRTX
$93.9M
| $9.18M | ﹤0.01% |
290,094
-160,597
| -36% | -$5.98M |
|
1694
Saic
SAIC
$4.95B
| $9.18M | ﹤0.01% |
113,868
-2,377
| -2% | -$202K |
|
|
RUBY
1695
DELISTED
Rubius Therapeutics, Inc
RUBY
| $9.17M | ﹤0.01% |
+381,902
| New | +$8.73M |
|
|
COR
1696
DELISTED
Coresite Realty Corporation
COR
| $9.16M | ﹤0.01% |
82,392
-6,596
| -7% | -$751K |
|
1697
ManpowerGroup
MAN
$2.44B
| $9.15M | ﹤0.01% |
106,430
-1,975
| -2% | -$176K |
|
|
SNBR
1698
DELISTED
Sleep Number
SNBR
| $9.15M | ﹤0.01% |
248,737
+16,297
| +7% | +$529K |
|
|
RTEC
1699
DELISTED
Rudolph Technologies Inc
RTEC
| $9.15M | ﹤0.01% |
374,039
-236,971
| -39% | -$6.53M |
|
1700
Nu Skin
NUS
$252M
| $9.13M | ﹤0.01% |
110,815
-19,631
| -15% | -$1.56M |
|
Similar funds
Invesco's Q3 2018 Portfolio in Review
As of Q3 2018, Invesco held 4,003 positions worth $318B, up 5.2% from $302B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Invesco's Q3 2018 filing shows 124 new, 1,958 increased, 1,647 reduced and 117 closed positions. Its largest new stake was Hanger Inc.: 3,856,471 shares worth $80.3M. The largest sale was Pfizer, an estimated $377M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Invesco's largest Q3 2018 buy was Hanger Inc.: 3,856,471 shares worth $80.3M.
- Invesco added most to PepsiCo in Q3 2018, an estimated $1.42B increase.
- Invesco's biggest Q3 2018 reduction was Pfizer, cutting an estimated $377M.
- Invesco fully exited GGP Inc. in Q3 2018, selling an estimated $250M.
- Invesco's ten largest holdings make up 18% of its $318B portfolio in Q3 2018.
- Invesco opened 124 new positions and closed 117 in Q3 2018.
- Invesco's portfolio value rose 5.2% quarter-over-quarter to $318B.
Based on Invesco's 13F filing for Q3 2018, filed 14 Nov 2018.